"STEMI: The Stakes": A video presentation by Sameer Mehta, MD, at the March 8th Nurse & Technologist Symposium at CRT 2026, held March 7-10 in Washington, D.C.
"STEMI: The Stakes": A video presentation by Sameer Mehta, MD, at the March 8th Nurse & Technologist Symposium at CRT 2026, held March 7-10 in Washington, D.C.
Dr. Alaswad reflects on how complex PCI is moving into longer, more calcified, higher-risk cases. Cumulative radiation exposure and the physical toll of protection are becoming career-defining issues. Protecting the team is not optional.
Dr. Alaswad reflects on how complex PCI is moving into longer, more calcified, higher-risk cases. Cumulative radiation exposure and the physical toll of protection are becoming career-defining issues. Protecting the team is not optional.
What does it look like to run a modern cath lab outside the U.S.? Jason Money, RN, RCIS, shares a unique perspective shaped by more than two decades working in New Zealand’s public healthcare system.
What does it look like to run a modern cath lab outside the U.S.? Jason Money, RN, RCIS, shares a unique perspective shaped by more than two decades working in New Zealand’s public healthcare system.
Brian C. Case, MD; Bailey Ann Richardson, MSN, AGNP, RN-BC, RNFA, CNOR, RCIS
Bailey Richardson, MSN, speaks with Brian Case, MD, about coronary microvascular dysfunction and why “normal” angiography can miss the cause of symptoms in patients with angina with non-obstructive coronary arteries (ANOCA).
Bailey Richardson, MSN, speaks with Brian Case, MD, about coronary microvascular dysfunction and why “normal” angiography can miss the cause of symptoms in patients with angina with non-obstructive coronary arteries (ANOCA).
In this 29-minute video (chapters available), Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring with the CardioMEMS™ HF System made by Abbott shifts management from reactive to proactive by detecting hemodynamic...
In this 29-minute video (chapters available), Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring with the CardioMEMS™ HF System made by Abbott shifts management from reactive to proactive by detecting hemodynamic...
In this 29-minute podcast, Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring shifts management from reactive to proactive by detecting hemodynamic congestion before clinical deterioration occurs.
In this 29-minute podcast, Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring shifts management from reactive to proactive by detecting hemodynamic congestion before clinical deterioration occurs.
In this 35-minute podcast, Dr. Kaple discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
In this 35-minute podcast, Dr. Kaple discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
New resources give hospital administrators, cath lab teams, and policymakers practical tools to implement Enhanced Radiation Safety Devices (ERPDs) and the ALARA+ safety framework.
New resources give hospital administrators, cath lab teams, and policymakers practical tools to implement Enhanced Radiation Safety Devices (ERPDs) and the ALARA+ safety framework.
Enrollment by Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital marks a significant milestone in the clinical evaluation of AngioInsight's investigational AngioAI+™ platform.
Enrollment by Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital marks a significant milestone in the clinical evaluation of AngioInsight's investigational AngioAI+™ platform.
The TECTONIC CAD IVL trial enrolled 335 patients across 40 U.S. clinical sites, with first pivotal trial data expected to be presented at TCT later this year.
The TECTONIC CAD IVL trial enrolled 335 patients across 40 U.S. clinical sites, with first pivotal trial data expected to be presented at TCT later this year.
With a record number of ASCs included, the latest Leapfrog ratings expand public reporting of ambulatory surgery center quality and safety, increasing transparency for patients and referring providers.
With a record number of ASCs included, the latest Leapfrog ratings expand public reporting of ambulatory surgery center quality and safety, increasing transparency for patients and referring providers.
The Cleerly Polygenic Cardiovascular Risk Score Test, powered by Allelica’s proprietary multi-ancestry PRS technology, gives physicians a new option to identify and evaluate patients with an inherited predisposition to coronary plaque.
The Cleerly Polygenic Cardiovascular Risk Score Test, powered by Allelica’s proprietary multi-ancestry PRS technology, gives physicians a new option to identify and evaluate patients with an inherited predisposition to coronary plaque.
First and only biomarker to measure coronary inflammation and assess cardiovascular mortality risk, enabling personalized disease management. CaRi-Heart Risk score identifies cardiovascular risk 10 years in advance.
First and only biomarker to measure coronary inflammation and assess cardiovascular mortality risk, enabling personalized disease management. CaRi-Heart Risk score identifies cardiovascular risk 10 years in advance.
Implicity’s newly cleared ILR ECG algorithm can now analyze data from ICMs across all major device manufacturers, including Abbott, Biotronik, Boston Scientific, and Medtronic.
Implicity’s newly cleared ILR ECG algorithm can now analyze data from ICMs across all major device manufacturers, including Abbott, Biotronik, Boston Scientific, and Medtronic.
ESC Press Release
Sophia Antipolis, France – 23 July 2026: The results of 59 ground-breaking trials will be unveiled for the first time at ESC Congress 2026, the annual congress of the European Society of Cardiology, which takes...
ESC Press Release
Sophia Antipolis, France – 23 July 2026: The results of 59 ground-breaking trials will be unveiled for the first time at ESC Congress 2026, the annual congress of the European Society of Cardiology, which takes...
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...